EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Evolution of Theories on Doxorubicin-Induced Late Cardiotoxicity-Role of Topoisomerase

Jaroslaw Szponar, Erwin Ciechanski, Magda Ciechanska iD, Jaroslaw Dudka, Sławomir Mandziuk

International Journal of Molecular Sciences · 18.12.2024 · 25 (24) · 13567

DOI: 10.3390/ijms252413567 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.12.2024. Verfasst von Jaroslaw Szponar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Toxicology Clinic, Faculty of Medicine, Medical University of Lublin, Krasnicka 100, 20-718 Lublin, Poland. Hauptthemen laut MEDLINE: Cardiotoxicity, DNA Topoisomerases, Type II, Doxorubicin. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 188 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Lublin.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Doxorubicin (DOX) has been widely used as a cytotoxic chemotherapeutic. However, DOX has a number of side effects, such as myelotoxicity or gonadotoxicity, the most dangerous of which is cardiotoxicity. Cardiotoxicity can manifest as cardiac arrhythmias, myocarditis, and pericarditis; life-threatening late cardiotoxicity can result in heart failure months or years after the completion of chemotherapy. The development of late cardiomyopathy is not yet fully understood. The most important question is how DOX reprograms the cardiomyocyte, after which DOX is excreted from the body, initially without symptoms. However, clinically overt cardiomyopathy develops over the following months and years. Since the 1980s, DOX-induced disorders in cardiomyocytes have been thought to be related to oxidative stress and dependent on the Fe/reactive oxygen species (ROS) mechanism. That line of evidence was supported by dexrazoxane (DEX) protection, the only Food and Drug Administration (FDA)-approved drug for preventing DOX-induced cardiomyopathy, which complexes iron. Thus, the hypothesis related to Fe/ROS provides a plausible explanation for the induction of the development of late cardiomyopathy via DOX. However, in subsequent studies, DEX was used to identify another important mechanism in DOX-induced cardiomyopathy that is related to topoisomerase 2β (Top2β). Does the Top2β hypothesis explain the mechanisms of the development of DOX-dependent late heart failure? Several of these mechanisms have been identified to date, proving the involvement of Top2β in the regulation of the redox balance, including oxidative stress. Thus, the development of late cardiomyopathy can be explained based on mechanisms related to Top2β. In this review, we highlight free radical theory, iron imbalance, calcium overload, and finally, a theory based on Top2β.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CardiotoxicityDNA Topoisomerases, Type IIDoxorubicinAnimalsHumansAntibiotics, AntineoplasticCardiomyopathiesDexrazoxaneIronMyocytes, CardiacOxidative StressReactive Oxygen Species

Stichwörter der Autor:innen

anthracyclinecardiac molecular metabolismcardiotoxicitydexrazoxanedoxorubicintopoisomerase

Substanzen

Antibiotics, AntineoplasticDexrazoxaneDNA Topoisomerases, Type IIDoxorubicinIronReactive Oxygen Species

Autor:innen und Institutionen

  • Toxicology Clinic, Faculty of Medicine, Medical University of Lublin, Krasnicka 100, 20-718 Lublin, Poland.
  • Clinical Department of Toxicology and Cardiology, Regional Specialist Hospital, Krasnicka 100, 20-718 Lublin, Poland.
  • Department of Cardiology, Regional Specialist Hospital, Krasnicka 100, 20-718 Lublin, Poland.
  • Department of Pulmonary Diseases and Children Rheumatology, Medical University of Lublin, Antoniego Gebali 6, 20-093 Lublin, Poland.
  • Department of Toxicology, Medical University of Lublin, Jaczewskiego 8b, 20-090 Lublin, Poland.
  • Department of Pneumology, Oncology and Allergology, Medical University of Lublin, Jaczewskiego 8, 20-090 Lublin, Poland.

ORCID-Profile: Magda Ciechanska

Förderung

  • Medical University of Lublin

Zitieren

APA

Szponar, J., Ciechanski, E., Ciechanska, M., Dudka, J., & Mandziuk, S. (2024). Evolution of Theories on Doxorubicin-Induced Late Cardiotoxicity-Role of Topoisomerase. International Journal of Molecular Sciences, 25(24), 13567. https://doi.org/10.3390/ijms252413567

Vancouver

Szponar J, Ciechanski E, Ciechanska M, Dudka J, Mandziuk S. Evolution of Theories on Doxorubicin-Induced Late Cardiotoxicity-Role of Topoisomerase. International Journal of Molecular Sciences. 2024;25(24):13567. doi:10.3390/ijms252413567

BibTeX
@article{Szponar2024,
  author = {Szponar, Jaroslaw and Ciechanski, Erwin and Ciechanska, Magda and Dudka, Jaroslaw and Mandziuk, Sławomir},
  title = {Evolution of Theories on Doxorubicin-Induced Late Cardiotoxicity-Role of Topoisomerase},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {24},
  pages = {13567},
  doi = {10.3390/ijms252413567}
}
Kostenlos starten →